Presley R W, Menétrey D, Levine J D, Basbaum A I
Department of Anesthesia, University of California San Francisco 94143.
J Neurosci. 1990 Jan;10(1):323-35. doi: 10.1523/JNEUROSCI.10-01-00323.1990.
Previous experiments have shown that noxious stimulation increases expression of the c-fos proto-oncogene in subpopulations of spinal cord neurons. c-fos expression was assessed by immunostaining for Fos, the nuclear phosphoprotein product of the c-fos gene. In this study, we examined the effect of systemic morphine on Fos-like immunoreactivity (FLI) evoked in the formalin test, a widely used model of persistent pain. Awake rats received a subcutaneous 150 microliters injection of 5% formalin into the plantar aspect of the right hindpaw. The pattern of nuclear FLI was consistent with the known nociceptive primary afferent input from the hindpaw. Dense labeling was recorded in the superficial dorsal horn (laminae I and IIo) and in the neck of the dorsal horn (laminae V and VI), areas that contain large populations of nociceptive neurons. Sparse labeling was noted in lamina IIi and in the nucleus proprius (laminae III and IV), generally considered to be nonnociceptive areas of the cord. Fos immunoreactivity was also evoked in the ventromedial gray, including laminae VII, VIII, and X. There was no labeling in lamina IX of the ventral horn. Since FLI was time dependent and distributed over several spinal segments, we focused our analysis where maximal staining was found (L3-L5) and at the earliest time point of the peak Fos immunoreactivity (2 hr). Twenty minutes prior to the formalin injection, the rats received morphine (1.0, 2.5, 5.0, or 10 mg/kg, s.c.) or saline vehicle. Two hours later, the rats were killed, their spinal cords removed, and 50 microns transverse sections of the lumbar enlargement were immunostained with a rabbit polyclonal antiserum directed against Fos. Prior treatment with morphine sulfate profoundly suppressed formalin-evoked FLI in a dose-dependent and naloxone-reversible manner. The dose-response relationship of morphine-induced suppression of FLI varied in different laminae. To quantify the effect of morphine on FLI, labeled neurons in sections taken from the L4/5 level of each rat were plotted with a camera lucida and counted. Staining in the neck of the dorsal horn (laminae V and VI) and in more ventral laminae VII, VIII, and X, was profoundly suppressed by doses of morphine which also suppress formalin-evoked behavior. Although the labeling was also significantly reduced in laminae I and II, at the highest doses of morphine there was substantial residual labeling in the superficial dorsal horn. These data indicate that analgesia from systemic opiates involves differential regulation of nociceptive processing in subpopulations of spinal nociceptive neurons.
先前的实验表明,伤害性刺激会增加脊髓神经元亚群中c-fos原癌基因的表达。通过对Fos进行免疫染色来评估c-fos的表达,Fos是c-fos基因的核磷蛋白产物。在本研究中,我们检测了全身应用吗啡对福尔马林试验中诱发的Fos样免疫反应性(FLI)的影响,福尔马林试验是一种广泛应用的持续性疼痛模型。清醒大鼠右后爪足底皮下注射150微升5%福尔马林。核FLI的模式与已知的来自后爪的伤害性初级传入输入一致。在浅表背角(I层和IIo层)以及背角颈部(V层和VI层)记录到密集标记,这些区域含有大量伤害性神经元。在IIi层和固有核(III层和IV层)观察到稀疏标记,这些区域通常被认为是脊髓的非伤害性区域。在腹内侧灰质,包括VII层、VIII层和X层也诱发了Fos免疫反应性。腹角IX层没有标记。由于FLI具有时间依赖性且分布在多个脊髓节段,我们将分析重点放在染色最强的部位(L3-L5)以及Fos免疫反应性峰值出现的最早时间点(2小时)。在注射福尔马林前20分钟,大鼠接受吗啡(1.0、2.5、5.0或10mg/kg,皮下注射)或生理盐水。两小时后,处死大鼠,取出脊髓,用针对Fos的兔多克隆抗血清对腰膨大处50微米厚的横切片进行免疫染色。预先用硫酸吗啡治疗以剂量依赖性和纳洛酮可逆的方式显著抑制了福尔马林诱发的FLI。吗啡诱导的FLI抑制的剂量反应关系在不同层中有所不同。为了量化吗啡对FLI的影响,用明箱描绘并计数每只大鼠L4/5水平切片中的标记神经元。背角颈部(V层和VI层)以及更靠腹侧的VII层、VIII层和X层的染色被能抑制福尔马林诱发行为的吗啡剂量显著抑制。尽管I层和II层的标记也显著减少,但在最高吗啡剂量下,浅表背角仍有大量残留标记。这些数据表明,全身应用阿片类药物产生的镇痛作用涉及对脊髓伤害性神经元亚群中伤害性处理的差异调节。